Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Jul-22 9:28 PM View:  | Prokidney Corp. (PROK) | 11-Jul-22 | Grant | 30,000 | -- | -- | 100% 0 to 30.0K | |
| 28-Jan-21 7:00 PM View: | Eidos Therapeutics, Inc. (EIDX) | 26-Jan-21 | Disposition (change in control) | 303,525 | -- | -- | (100%) 303.52K to 0 | |
| 15-Jan-21 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 13-Jan-21 | Market Sale (Planned) | 10,000 | $124.32 | $1,243,180.00 | (3%) 316.52K to 306.52K | (3%) |
| 04-Dec-20 5:34 PM View: | Eidos Therapeutics, Inc. (EIDX) | 02-Dec-20 | Market Sale (Planned) | 5,000 | $90.04 | $450,187.00 | (2%) 321.52K to 316.52K | (43%) |
| 18-Nov-20 7:39 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-20 | Option Exercise | 469 | -- | -- | 3% 15.99K to 16.46K | |
| 30-Oct-20 4:55 PM View: | Eidos Therapeutics, Inc. (EIDX) | 29-Oct-20 | Market Sale (Planned) | 5,000 | $72.42 | $362,099.00 | (2%) 326.52K to 321.52K | (77%) |
| 28-Jan-21 7:00 PM View: | Eidos Therapeutics, Inc. (EIDX) | 27-Oct-20 | Gift | 3,000 | -- | -- | (< 1%) 306.52K to 303.52K | |
| 02-Oct-20 7:43 PM View: | Eidos Therapeutics, Inc. (EIDX) | 01-Oct-20 | Market Sale (Planned) | 4,831 | $52.35 | $252,923.00 | (1%) 331.36K to 326.52K | (145%) |
| 02-Oct-20 7:43 PM View: | Eidos Therapeutics, Inc. (EIDX) | 30-Sep-20 | Market Sale (Planned) | 169 | $52.03 | $8,793.52 | (< 1%) 331.52K to 331.36K | (147%) |
| 18-Aug-20 7:03 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-20 | Option Exercise | 468 | -- | -- | 3% 15.52K to 15.99K | |
| 05-Jun-20 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 31-May-20 | Grant | 444 | $41.57 | $18,458.60 | < 1% 331.08K to 331.52K | |
| 21-May-20 4:18 PM View: | Bridgebio Pharma, Inc. (BBIO) | 19-May-20 | Grant | 1,523 | -- | -- | 11% 14.0K to 15.52K | |
| 20-Dec-19 4:32 PM View: | Eidos Therapeutics, Inc. (EIDX) | 18-Dec-19 | Market Sale | 12,500 | $61.90 | $773,794.00 | (4%) 343.58K to 331.08K | (107%) |
| 27-Sep-19 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 25-Sep-19 | Market Sale | 2,500 | $38.41 | $96,016.40 | (< 1%) 346.08K to 343.58K | (234%) |
| 29-Jul-19 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 25-Jul-19 | Market Sale | 5,000 | $36.13 | $180,627.00 | (1%) 351.08K to 346.08K | (255%) |
| 03-Jul-19 4:17 PM View: | Bridgebio Pharma, Inc. (BBIO) | 01-Jul-19 | Purchase | 14,000 | $17.00 | $238,000.00 | 100% 0 to 14.0K | |
| 29-Jul-19 4:05 PM View: | Eidos Therapeutics, Inc. (EIDX) | 31-May-19 | Grant | 1,769 | $12.01 | $21,246.60 | < 1% 349.31K to 351.08K | |
| 28-May-19 4:01 PM View: | Eidos Therapeutics, Inc. (EIDX) | 23-May-19 | Market Sale | 5,000 | $27.28 | $136,376.00 | (1%) 354.31K to 349.31K | (371%) |
| 28-May-19 4:01 PM View: | Eidos Therapeutics, Inc. (EIDX) | 30-Nov-18 | Grant | 1,081 | $12.01 | $12,982.80 | < 1% 353.23K to 354.31K |